Valvular Spotlight: Breakthrough Transcatheter PV Treatment Option for Adult/Pediatric CHD Patients

Learn more about Harmony™ Transcatheter Pulmonary Valve (TPV) from Medtronic: the first minimally invasive alternative for patients with severe pulmonary regurgitation who have a native or surgically-repaired right ventricular outflow tract (RVOT) and are clinically indicated for surgical pulmonary valve replacement. Harmony TPV allows a broader range of congenital heart disease patients access to transcatheter technology, thus fulfilling a significant unmet clinical need. This novel therapy recently received FDA approval and is now available for use in the United States.
Speaker:
Jamil A. Aboulhosn, MD
UCLA Health
Sponsored by Medtronic
#ACHD #CHD #cvVHD #ACC21